Mr. Christopher Hopton reports

SIRONA BIOCHEM ANNOUNCES 2023 ANNUAL MEETING RESULTS

Sirona Biochem Corp. has released the voting results from its annual general meeting of shareholders, held in Vancouver, B.C., on March 28, 2024. The total number of shares represented by shareholders present in person and by proxy at the meeting was 26,722,196, representing 10.52 per cent of Sirona's issued and outstanding common shares.

All matters put forward to shareholders for consideration and approval, as set out in the company's management information circular dated Feb. 22, 2024, were approved by the requisite majority of votes cast at the meeting. These were:

1. To elect Sirona's board of directors;
2. To fix the number of directors of the company at five;
3. To appoint Davidson & Company LLP, chartered professional accountants, as the company's auditor for the ensuing year and authorize the directors to set the auditor's remuneration;
4. To confirm and approve the company's existing stock option plan.

Sirona would like to thank all shareholders for their continued support.

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and continuing royalty payments. Sirona's laboratory, TFChem, is located in France and is the recipient of multiple French national scientific awards and European Union and French government grants.

We seek Safe Harbor.